scholarly journals The Rome criteria divides, distorts and dilutes the prevalence of irritable bowel syndrome

2010 ◽  
Vol 16 (3) ◽  
pp. 143 ◽  
Author(s):  
Kok-Ann Gwee ◽  
UdayC Ghoshal
Keyword(s):  
Irritable Bowel Syndrome ◽  
Rome Criteria ◽  
Irritable Bowel

scholarly journals Level of chronic life stress predicts clinical outcome in irritable bowel syndrome

Gut ◽  
1998 ◽  
Vol 43 (2) ◽  
pp. 256-261 ◽  
Author(s):  
E J Bennett ◽  
C C Tennant ◽  
C Piesse ◽  
C-A Badcock ◽  
J E Kellow
Keyword(s):  
Irritable Bowel Syndrome ◽  
Clinical Outcome ◽  
Life Stress ◽  
Research Evidence ◽  
Powerful Predictor ◽  
Rome Criteria ◽  
Intensity Measures ◽  
Symptom Intensity ◽  
Irritable Bowel ◽  
Over Time

Background—Life stress contributes to symptom onset and exacerbation in the majority of patients with irritable bowel syndrome (IBS) and functional dyspepsia (FD); research evidence is conflicting, however, as to the strength of these effects.Aims—To test prospectively the relation of chronic life stress threat to subsequent symptom intensity over time.Patients—One hundred and seventeen consecutive outpatients satisfying the modified Rome criteria for IBS (66% with one or more concurrent FD syndromes) participated.Methods—The life stress and symptom intensity measures were determined from interview data collected independently at entry, and at six and 16 months; these measures assessed the potency of chronic life stress threat during the prior six months or more, and the severity and frequency of IBS and FD symptoms during the following two weeks.Results—Chronic life stress threat was a powerful predictor of subsequent symptom intensity, explaining 97% of the variance on this measure over 16 months. No patient exposed to even one chronic highly threatening stressor improved clinically (by 50%) over the 16 months; all patients who improved did so in the absence of such a stressor.Conclusion—The level of chronic life stress threat predicts the clinical outcome in most patients with IBS/FD.

ROME Criteria for Irritable Bowel Syndrome (IBS) Should Be a Quantitative Trait and Not a Qualitative Trait

2008 ◽  
Vol 103 ◽  
pp. S471-S472
Author(s):  
Yuri Saito-Loftus ◽  
Ann Almazar-Elder ◽  
Joseph Larson ◽  
Elizabeth Atkinson ◽  
Nicholas Talley
Keyword(s):  
Irritable Bowel Syndrome ◽  
Quantitative Trait ◽  
Rome Criteria ◽  
Qualitative Trait ◽  
Irritable Bowel

T1024 Systematic Review of the Utility of the Manning and ROME Criteria in the Diagnosis of Irritable Bowel Syndrome

2008 ◽  
Vol 134 (4) ◽  
pp. A-467 ◽  
Author(s):  
Alexander C. Ford ◽  
Nicholas J. Talley ◽  
Sander Veldhuyzen van Zanten ◽  
Nimish Vakil ◽  
Paul Moayyedi
Keyword(s):  
Systematic Review ◽  
Irritable Bowel Syndrome ◽  
Rome Criteria ◽  
Irritable Bowel

scholarly journals Actual issues of diagnosis and treatment of irritable bowel syndrome

2019 ◽  
pp. 110-116
Author(s):  
D. I. Trukhan ◽  
V. V. Goloshubina ◽  
D. S. Ivanova
Keyword(s):  
Irritable Bowel Syndrome ◽  
Diagnostic Criteria ◽  
Clinical Manifestations ◽  
Diagnosis And Treatment ◽  
Bifidobacterium Infantis ◽  
Rome Criteria ◽  
International Consensus ◽  
Incorrect Diagnosis ◽  
Irritable Bowel ◽  
Number Of Publications

The problem of irritable bowel syndrome (IBS) remains relevant for practice internist and gastroenterologist, as evidenced by the large number of publications in recent years on this issue, affecting various aspects of the pathogenesis, clinical manifestations, diagnosis and treatment of IBS. The article describes the evolution of diagnostic criteria for IBS as part of an international consensus «Rome criteria». Lack of effect of the treatment of IBS ex juvantibus often not a consequence of an incorrect diagnosis, and due to the presence in the patient’s intestinal disorders microbiocenosis. In this situation, it is expedient to correct the microbial landscape of the intestine with the use of probiotic agents. Efficacy in reducing the symptoms of irritable bowel syndrome has reliably demonstrated specific strains of probiotics, such as Bifidobacterium infantis 35624.

scholarly journals Irritable Bowel Syndrome: The Most Common Presentation, Severity Ranking and Therapeutic Regimens among Patients Attending Outpatient

2020 ◽  
Vol 16 (1) ◽  
pp. 10-17
Author(s):  
Zaid I. Al-Attar
Keyword(s):  
Irritable Bowel Syndrome ◽  
High School Graduates ◽  
Rome Criteria ◽  
Cross Sectional ◽  
Common Presentation ◽  
Functional Gi Disorders ◽  
Crampy Abdominal Pain ◽  
Irritable Bowel ◽  
Internal Medicine Clinic

Background: Irritable bowel syndrome (IBS) is one of the most common GI disorders in people under 50 years of age.Objective: To Formulate an overview about demographics of IBS and patterns of presentation, to determine IBS patients severity ranking, and to recognize the main regimens with their patient satisfaction.Methods: This is a cross sectional clinical study that is conducted in Outpatient Consultant Internal Medicine Clinic in Al-Kindy Teaching Hospital from 11/12/2017 to 24/12/2017. The patients suffering from IBS are diagnosed by a consultant according to the symptom-based Rome criteria for functional GI disorders, by implementing a questionnaire collecting thorough information. 77 cases of IBS patients were collected (24 male and 53 female).Results: This study revealed that majority of patients were female (68.8%). Most of the patients were married, employees and housewives, aged between (20-30 yrs). Most patients use anxiolytics, muscle relaxants and proton pump inhibitor. There is a high IBS prevalence among low educational level (high school graduates and non-school graduates).Most patients in our study had constipation.Aggravating factors Psychological factors (stress) are intrinsically associated with IBS and symptoms in a large percentage of patients.Antispasmodics usage in our study show high effectiveness for IBS patients especially those with crampy abdominal pain and diarrhea.Conclusions: Diagnosing and managing IBS can be a big challenge since many drugs used to reduce symptoms and severity, but also, they could be unnecessary medication that could aggravate bowel symptoms and have adverse effects on the long term.

scholarly journals Irritable Bowel Syndrome Subtypes: New Names for Old Medical Conditions

2019 ◽  
Vol 38 (Suppl. 2) ◽  
pp. 122-127 ◽  
Author(s):  
Simona Grad  ◽  
Dan L. Dumitrascu
Keyword(s):  
Irritable Bowel Syndrome ◽  
Scientific Evidence ◽  
Healthcare Providers ◽  
Gastrointestinal Disorder ◽  
Rome Criteria ◽  
Conceptual Changes ◽  
Diagnosis And Classification ◽  
Criteria For Diagnosis ◽  
Irritable Bowel

The irritable bowel syndrome (IBS) is the most common functional gastrointestinal disorder (FGID), also called disorders of the gut-brain interaction (DGBI). Over the years, the definition and classification of IBS suffered several conceptual changes. The work of the Rome Committees has largely contributed to the progress in knowledge and awareness of IBS. This paper is an overview of the evolution of diagnosis and classification criteria of IBS. Background: The majority of the complaints causing presentation to the general gastroenterological centers are represented by FGID. IBS is the most frequent among them. IBS is not a uniform condition but includes an array of particular forms called subtypes. Criteria for the identification of the IBS subtypes have suffered several changes in parallel with the accumulation of scientific evidence about this disorder. Classification of IBS subtypes relies on symptoms. Summary: This is a review of the evolution of the criteria for diagnosis and classification of IBS subtypes. Starting with older names given to IBS, some changes in definition and diagnosis have been operated by each edition of the Rome criteria. These changes have led to the better identification of patients with IBS. The management of IBS depends on subtypes and should be individualized. Key Messages: IBS is the main FGID, called also DGBI. It is not a homogenous disorder but a generic name for an array of subtypes with common features but with clinical differences. The diagnosis and classification of IBS subtypes have evolved in time, in accordance with the progress of the knowledge on pathogenesis. It is important for healthcare providers to recognize the subtypes and to use a common nomenclature (that offered by the Rome Committees work).

Sign in / Sign up

Export Citation Format

Share Document